Las Vegas, NV -- (SBWIRE) -- 10/04/2013 -- EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more .EquityObserver.com issues a special report on the following stocks: Triangle Petroleum Corporation (NYSEMKT: TPLM), Comstock Resources Inc (NYSE:CRK), Inergy Midstream L P (NYSE:NRGM), Curis, Inc. (NASDAQ:CRIS)
Triangle Petroleum Corporation (NYSEMKT: TPLM) managed to keep its gain at 0.87% on below -normal volume of 1.56M shares. The stock settled at $10.39 after floating in a range of $10.07 to $10.48. Its latest price has reached market capitalization of $25 million. Its 52-week range has been $6 to $8. Triangle Petroleum Corporation (Triangle) is an exploration and production company ,which is focused on the development of unconventional shale oil and natural gas resources in the Bakken Shale and Three Forks formations in the Williston Basin of North Dakota and Montana.
For How Long TPLM will fight for Profitability? Read This Trend Analysis report
Comstock Resources Inc (NYSE:CRK) traded up on a volume of 1.54 million, higher than its standard daily volume. Shares have gained 5.49% to $17.11. Over the last twelve months, the stock has lost-6.91% and faced a worst price of $12.83. Comstock Resources Inc (Comstock) is engaged in the acquisition, development, production and exploration of oil and natural gas.
For How Long CRK’s Gloss will Attract Investors? Find out via this report
Inergy Midstream L P (NYSE:NRGM) settled 2.63% higher at $23.03 on above-normal volume of 1.53M shares during the last trading day. The stock has its 12-month high at $26.01 and 52-week low price was $21.03. It traded in a range of $22.49 to $23.10 during the last trading day. Inergy Midstream, L.P., formerly Inergy Midstream, LLC, is a limited partnership formed by Inergy, L.P. (NRGY) to own, operate, develop and acquire midstream energy assets. As of September 30, 2011.
Why Should Investors Buy NRGM After the Recent Fall? Just Go Here and Find Out
In the last trading session, Curis, Inc. (NASDAQ:CRIS) was down on high volume, trading at a volume of 1.51M versus its average daily volume of 549,770.00 shares. At $-2.59, the stock has attained market capitalization of 368.44 million. Curis, Inc. is a drug discovery and development company that is committed to leveraging signaling pathway drug technologies in seeking to develop next generation network-targeted cancer therapies.
Why Should Investors Buy CRIS After the Recent Fall? Just Go Here and Find Out
About Equity Observer
Equity Observer delivers intra-day insights into the equities, tech and investment world. The website is a window into what’s going on in the business world and why.
EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more.
The disclaimer is to be read and fully understood before using our site, or joining our email list.
http://www.equityobserver.com/ has a no tolerance spam policy; we will not sell or re-distribute your email to any 3rd party. A If applicable, please also unsubscribe from the newsletter using the link at the bottom of the email if you no longer wish to receive our emails. We only send our newsletters to opt-in members.
PLEASE NOTE WELL: The http://www.equityobserver.com/" rel="nofollow" href="http://www.equityobserver.com/"> http://www.equityobserver.com/>
Employees and contributors are NOT registered as an Investment Adviser in any jurisdiction whatsoever.
Read Full Disclaimerat: http://www.equityobserver.com/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)